Wednesday, June 10, 2026
🇺🇸 FDA

Intelligence · Patents

Patents expiring in 2034

Annual patent cliff calendar for 2034 — US pharmaceutical patents by expiration date.

Patents
1,452

Quick answer

1,452 indexed pharmaceutical patents have expiration dates in 2034. Browse by soonest expiry with links to assignee companies and related drugs.

  1. US 8697744

    Substituted 5,6-dihydro-4H-thiazolo[4,5-E]indazoles and their use as positive allosteric modulators of metabotropic glutamate receptors

    Addex Pharma, S.A. · Granted Tue Apr 15 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 8697048

    Peptide amphiphile suspension to prevent or reduce tumor formation from administered embryonic stem cells

    Northwestern University · Granted Tue Apr 15 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 8697125

    Tablet preparation without causing a tableting trouble

    Takeda Pharmaceutical Company Limited · Granted Tue Apr 15 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 8697856

    Plasmodium vivax hybrid circumsporozoite protein and vaccine

    The United States of America as represented by the Secretary of the Army · Granted Tue Apr 15 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 8697628

    Methods of using AMPD2 inhibitors for the treatment of fatty liver, obesity and diabetes

    The Regents of the University of Colorado, a Body Corporate · Granted Tue Apr 15 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 8697034

    Hyperpolarized 89-yttrium and methods relating thereto

    The Board of Regents of the University of Texas System · Granted Tue Apr 15 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 8697633

    Dissolution of arterial plaque

    Atheronova Operations, Inc. · Granted Tue Apr 15 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 8697865

    Cyclic amide derivative, and its production and use

    Takeda Pharmaceutical Company Limited · Granted Tue Apr 15 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 8697699

    Imidazopyrazine SYK inhibitors

    GILEAD CONNECTICUT, INC. · Granted Tue Apr 15 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 8697858

    Antisense antiviral compound and method for treating influenza viral infection

    Sarepta Therapeutics, Inc. · Granted Tue Apr 15 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 8697874

    Heterocyclic compound and use thereof

    Takeda Pharmaceutical Company Limited · Granted Tue Apr 15 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 8697853

    TAL effector-mediated DNA modification

    Regents of the University of Minnesota · Granted Tue Apr 15 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 8697848

    Method for reducing immunogenicity of therapeutic protein compositions

    The Regents of the University of Colorado · Granted Tue Apr 15 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 8697709

    Fused ring heteroaryl kinase inhibitors

    The Regents of the University of California · Granted Tue Apr 15 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 8697730

    5-lipoxygenase activating protein (FLAP) inhibitor

    Panmira Pharmaceuticals, LLC · Granted Tue Apr 15 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 8697724

    Crystalline oxalate salts of a diamide compound

    Theravance, Inc. · Granted Tue Apr 15 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 8697727

    N-substituted-heterocycloalkyloxybenzamide compounds and methods of use

    Rigel Pharmaceuticals, Inc. · Granted Tue Apr 15 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 8697698

    Pyrazole compounds useful as protein kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Tue Apr 15 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 8697689

    Indole and benzomorpholine derivatives as modulators of metabotropic glutamate receptors

    Addex Pharma, S.A. · Granted Tue Apr 15 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 8697666

    Anti-cancer oligodeoxynucleotides

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Apr 15 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 8697649

    Polypeptides, nucleic acid molecule encoding polypeptides, and uses of polypeptides

    China Medical University · Granted Tue Apr 15 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 8697662

    Methods for treating Kaposi sarcoma

    PTC THERAPEUTICS, INC. · Granted Tue Apr 15 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. CA 2883399

    REDUCTION AU MINIMUM DE DEPOTS LIPIDIQUES BIOLOGIQUES SUR DES LENTILLES DE CONTACT

    BAUSCH & LOMB [US] · Granted Thu Apr 17 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Apr 12 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 8703758

    Bicyclic compound

    Takeda Pharmaceutical Company Limited · Granted Tue Apr 22 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 8703840

    Dental adhesive material kit

    KURARAY NORITAKE DENTAL INC. · Granted Tue Apr 22 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 8703730

    Complement antagonists and uses thereof

    REGENESANCE B.V. · Granted Tue Apr 22 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 8703098

    Labelled adrenomedullin derivatives and their use for imaging and therapy

    INSTITUT DE CARDIOLOGIE DE MONTREAL · Granted Tue Apr 22 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 8703096

    Beta-amyloid PET imaging agents

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Apr 22 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 8703987

    Methods for preparing 2-methoxyisobutylisonitrile and tetrakis(2-methoxyisobutylisonitrile)copper(I) tetrafluoroborate

    Draximage Limited · Granted Tue Apr 22 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 8703791

    3-carboxypropyl-aminotetralin derivatives and related compounds as mu opioid receptor antagonists

    Theravance, Inc. · Granted Tue Apr 22 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 8703800

    Nitrate and diazeniumdiolate derivatives of pioglitazone

    CARDIOLYNX AG · Granted Tue Apr 22 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 8703735

    Antisense antiviral compounds and methods for treating a filovirus infection

    Sarepta Therapeutics, Inc. · Granted Tue Apr 22 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 8703826

    Preparation of (R,R)-fenoterol and (R,R)-or (R,S)-fenoterol analogues and their use in treating congestive heart failure

    The United States of America as Represented by The Secretary of the Department of Health and Human Services National Institutes of Health Office of Technology Transfer · Granted Tue Apr 22 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 8703115

    Methods for preparing conjugates

    Nektar Therapeutics · Granted Tue Apr 22 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 8703150

    Methods of using Bacillus anthracis protective antigen sequences for vaccination

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Apr 22 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 8703756

    Synthetic procedure and cancer treatment with cisplatin derivatives

    THE BOARD OF REGENTS OF THE NEVADA SYSTEM OF HIGHER EDUCATION ON BEHALF OF THE UNIVERSITY OF NEVADA, LAS VEGAS · Granted Tue Apr 22 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 8703751

    Androstenediol as an indicator for assessing estrogenicity

    The Regents of the University of California · Granted Tue Apr 22 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 8703762

    Method of treating organophosphorous poisoning

    The United States of America as repr. by the Sec. of the Army, U.S. Army Med. Resr. Inst. of Chem. Defense · Granted Tue Apr 22 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 8703200

    Inhibition of neovascularization by cerium oxide nanoparticles

    The Board of Regents of the University of Oklahoma · Granted Tue Apr 22 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 8703208

    Nanometer mesoporous silica-based xerogel styptic process and its preparing process and application

    East China University of Science and Technology · Granted Tue Apr 22 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 8703726

    Methods for treating prostate conditions

    PTC THERAPEUTICS, INC. · Granted Tue Apr 22 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 8703727

    Nanotechnology formulation of poorly soluble compounds

    Aphios Corporation · Granted Tue Apr 22 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 8703134

    Targeted cryptosporidium biocides

    Arizona Board of Regents on Behalf of the University of Arizona · Granted Tue Apr 22 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 8703489

    Methods and compositions for targeted single-stranded cleavage and targeted integration

    Sangamo Biosciences, Inc. · Granted Tue Apr 22 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 8703186

    Abuse-resistant oral dosage forms and method of use thereof

    Elite Laboratories, Inc. · Granted Tue Apr 22 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 8703136

    Complement inhibition for improved nerve regeneration

    REGENESANCE B.V. · Granted Tue Apr 22 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 8703140

    Inhibition of factor B, the alternative complement pathway and methods related thereto

    The Regents of the University of Colorado, a Body Corporate · Granted Tue Apr 22 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 8703192

    Dosage form containing pantoprazole as active ingredient

    TAKEDA GMBH · Granted Tue Apr 22 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many pharma patents expire in 2034?

1,452 published patents in our USPTO index have expiration dates falling in calendar year 2034.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.